Diabetes Mellitus, Type 2 Clinical Trial
Official title:
Onduo Virtual Diabetes Clinic Platform Evaluation: A Pragmatic Comparative Effectiveness Trial in Primary Care
Onduo Virtual Diabetes Clinic Platform Evaluation: A Pragmatic Comparative Effectiveness Trial in Primary Care
More than 30 million Americans, nearly 10% of the U.S. population, have diabetes, with type 2
diabetes (T2D) accounting for over 90% of all diabetes cases. In addition, approximately 84.1
million Americans have prediabetes, a condition with high risk of advancing to T2D in 5 years
if not treated. This high prevalence of diabetes has created an enormous financial burden on
health care systems and has significantly affected the quality of life in those living with
diabetes. With the increasing population of older adults with T2D, this public health concern
is likely to become worse if not addressed.
Over the past decade, a growing body of evidence indicates that smartphones and connected
devices have the potential to reduce the burden of diabetes while improving patient care.
Access to continuous glucose monitoring (CGM) devices allows individuals to obtain a week of
dense glycemic information with a single sensor application, obviating the need for finger
sticks. CGM also provides patients with information regarding their glucose response to food
intake and activities in real-time, which enables health providers and patients to set
individualized lifestyle and medication adjustments to optimize glycemic control. Moreover,
mobile app technology on smartphones has progressed to enable remote, on-demand connections
with coaching and clinicians.
This study evaluates the Onduo Virtual Diabetes Clinic (VDC), a comprehensive diabetes
management program that combines mobile app technology, connected devices including blood
glucose (BG) meters and CGM devices, personalized lifestyle coaching, and remote clinical
support from board-certified endocrinologists. The lifestyle and clinical guidance follow the
best practices of the American Association of Diabetes Educators (AADE) Diabetes Education
Curriculum and the American Diabetes Association (ADA) Standards of Care. This study focuses
on evaluating the outcomes of the Onduo VDC in individuals with T2D with suboptimal glycemic
control.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
| Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
| Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
| Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
| Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
| Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
| Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
| Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
| Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
| Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |